Cardiol Therapeutics Inc. Share Price & Technical Analysis
CRDL · $1.32 (+0.76%)
Healthcare / Drug Manufacturers - Specialty & Generic
$1.32
+0.76%
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for …
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
-7% return in May, 19% avg return in past 3 year May month.
44% return in 2026, 45% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 11% | 40% | 0% | -7% | – | – | – | – | – | – | – | 44% |
| 25 | 8% | -15% | -17% | 10% | 9% | 8% | 7% | -27% | 0% | 0% | -9% | -9% | -35% |
| 24 | 50% | 75% | -18% | 11% | 30% | -23% | 10% | -14% | 5% | -10% | -16% | -24% | 77% |
| 23 | 40% | -29% | 0% | 20% | 17% | 50% | 22% | 0% | -18% | -11% | 13% | -11% | 92% |
| 22 | 0% | -6% | -17% | -7% | -7% | 0% | 0% | -15% | -9% | -45% | -17% | 0% | -123% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Uptrend · Neutral
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$145.74M
P/E ratio
—
52W high
$1.71
52W low
$0.88
Volume
2,81,359
Beta
0.42
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Cardiol Therapeutics Inc. share price today?
- Cardiol Therapeutics Inc. (CRDL) last traded around $1.32 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CRDL have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CRDL. Download the app for real-time alerts.
- How can I analyze Cardiol Therapeutics Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.